institutional conflict of interest and commercialization joyce brinton director, office for...
TRANSCRIPT
![Page 1: Institutional Conflict of Interest and Commercialization Joyce Brinton Director, Office for Technology and Trademark Licensing Harvard University Intellectual](https://reader033.vdocuments.mx/reader033/viewer/2022052401/56649cc15503460f949880b5/html5/thumbnails/1.jpg)
Institutional Conflict of Interest and Commercialization
Joyce Brinton
Director, Office for Technology and Trademark Licensing
Harvard University
Intellectual Property Summer Conference for Senior University ExecutivesJuly 27-28, 2001University of WashingtonSeattle, Washington
![Page 2: Institutional Conflict of Interest and Commercialization Joyce Brinton Director, Office for Technology and Trademark Licensing Harvard University Intellectual](https://reader033.vdocuments.mx/reader033/viewer/2022052401/56649cc15503460f949880b5/html5/thumbnails/2.jpg)
Institutional Conflicts of Interest
What are they?
Why worry about them?
What can we do manage them?
![Page 3: Institutional Conflict of Interest and Commercialization Joyce Brinton Director, Office for Technology and Trademark Licensing Harvard University Intellectual](https://reader033.vdocuments.mx/reader033/viewer/2022052401/56649cc15503460f949880b5/html5/thumbnails/3.jpg)
A Possible Definition?
An institutional conflict of interest exists when an activity that could result in a financial benefit for the institution could, at the same time, detract from, or appear to detract from, the institution’s primary mission.
![Page 4: Institutional Conflict of Interest and Commercialization Joyce Brinton Director, Office for Technology and Trademark Licensing Harvard University Intellectual](https://reader033.vdocuments.mx/reader033/viewer/2022052401/56649cc15503460f949880b5/html5/thumbnails/4.jpg)
Mission(s) of the Modern Research University
Education of students Advancing knowledge through research and scholarship Preservation and dissemination of knowledge Provision of clinical care (in the case of medical
schools/centers)
Public service to the community Technology transfer Economic development Community enrichment through public educational and
cultural activities
![Page 5: Institutional Conflict of Interest and Commercialization Joyce Brinton Director, Office for Technology and Trademark Licensing Harvard University Intellectual](https://reader033.vdocuments.mx/reader033/viewer/2022052401/56649cc15503460f949880b5/html5/thumbnails/5.jpg)
Every university has its own unique mission mix
![Page 6: Institutional Conflict of Interest and Commercialization Joyce Brinton Director, Office for Technology and Trademark Licensing Harvard University Intellectual](https://reader033.vdocuments.mx/reader033/viewer/2022052401/56649cc15503460f949880b5/html5/thumbnails/6.jpg)
Multiple Missions
Lure of Corporate Research
Funding
Potential Technology Transfer Income
Potential for Institutional Conflicts of Interest
Less emphasis on teaching Restrictions on publication
Reduced quality of education Delayed/censored
publications Reduced quality of clinical
care
Perceptions
![Page 7: Institutional Conflict of Interest and Commercialization Joyce Brinton Director, Office for Technology and Trademark Licensing Harvard University Intellectual](https://reader033.vdocuments.mx/reader033/viewer/2022052401/56649cc15503460f949880b5/html5/thumbnails/7.jpg)
Why worry?
Loss of public trust
Increasing federal concerns
Potential legal liability
![Page 8: Institutional Conflict of Interest and Commercialization Joyce Brinton Director, Office for Technology and Trademark Licensing Harvard University Intellectual](https://reader033.vdocuments.mx/reader033/viewer/2022052401/56649cc15503460f949880b5/html5/thumbnails/8.jpg)
How to manage?
That’s the big question!
![Page 9: Institutional Conflict of Interest and Commercialization Joyce Brinton Director, Office for Technology and Trademark Licensing Harvard University Intellectual](https://reader033.vdocuments.mx/reader033/viewer/2022052401/56649cc15503460f949880b5/html5/thumbnails/9.jpg)
First, you have to recognize that there is an issue.
Do you need a policy?
![Page 10: Institutional Conflict of Interest and Commercialization Joyce Brinton Director, Office for Technology and Trademark Licensing Harvard University Intellectual](https://reader033.vdocuments.mx/reader033/viewer/2022052401/56649cc15503460f949880b5/html5/thumbnails/10.jpg)
Who has an Institutional Conflict of Interest Policy?
Do you have other policies that address these issues?
![Page 11: Institutional Conflict of Interest and Commercialization Joyce Brinton Director, Office for Technology and Trademark Licensing Harvard University Intellectual](https://reader033.vdocuments.mx/reader033/viewer/2022052401/56649cc15503460f949880b5/html5/thumbnails/11.jpg)
Harvard does not have a specific ICOI Policy
IP Policy makes clear “public good” takes precedence over
“profit” teaching and research come before
technology transfer
Working on “Partnerships” Policy
![Page 12: Institutional Conflict of Interest and Commercialization Joyce Brinton Director, Office for Technology and Trademark Licensing Harvard University Intellectual](https://reader033.vdocuments.mx/reader033/viewer/2022052401/56649cc15503460f949880b5/html5/thumbnails/12.jpg)
Hypothetical Situations:A way to understand Institutional Conflicts of Interest
Think about: Primacy of Academic Mission - education and
research Freedom of Inquiry Open Exchange of Ideas Educational Welfare of Students Public Trust
![Page 13: Institutional Conflict of Interest and Commercialization Joyce Brinton Director, Office for Technology and Trademark Licensing Harvard University Intellectual](https://reader033.vdocuments.mx/reader033/viewer/2022052401/56649cc15503460f949880b5/html5/thumbnails/13.jpg)
Hypothetical Situation 1
The university's licensee (in which the university and the inventor hold stock) is about to initiate clinical trials of a drug based on the university's technology. It is proposed that some of those trials will take place at the university's medical center - although the inventor will not be directly involved.
Will the university’s equity holdings and the prospect of royalty income if the FDA approves the drug be perceived as influencing
the IRB review process? the reliability of the results of the trials themselves?
What will be the public reaction is there is an “adverse event” in the trials and a patient dies?
![Page 14: Institutional Conflict of Interest and Commercialization Joyce Brinton Director, Office for Technology and Trademark Licensing Harvard University Intellectual](https://reader033.vdocuments.mx/reader033/viewer/2022052401/56649cc15503460f949880b5/html5/thumbnails/14.jpg)
Hypothetical Situation 2
The university has licensed Professor X’s technology to a start-up company in which she is a founder and in which the university has received stock. Professor X encourages her students to work on projects that will, if successful, enhance the company’s ability to commercialize Professor X’s technology and thus the success of the company.
Is the university’s ability to judge whether these projects are in the best interest of the student compromised because it stands to gain financially if the projects are successful?
![Page 15: Institutional Conflict of Interest and Commercialization Joyce Brinton Director, Office for Technology and Trademark Licensing Harvard University Intellectual](https://reader033.vdocuments.mx/reader033/viewer/2022052401/56649cc15503460f949880b5/html5/thumbnails/15.jpg)
Hypothetical Situation 3
The university has licensed Professor A’s technology to a start up and has received stock as part of the license compensation. The company has licensed some competing technology from another university and is not currently developing Professor A’s technology. The company says it will do so in the future if the competing technology shows no advantages.
If the university does not terminate its license for default (a failure to meet development
milestones), will that decision be seen as being the result of a desire protect the value of the university’s stock?
Will that view persist if there are no other viable licensees for the technology?
![Page 16: Institutional Conflict of Interest and Commercialization Joyce Brinton Director, Office for Technology and Trademark Licensing Harvard University Intellectual](https://reader033.vdocuments.mx/reader033/viewer/2022052401/56649cc15503460f949880b5/html5/thumbnails/16.jpg)
Hypothetical Situation 4
A Fortune 500 company offers the university a very large research grant to support research in the information technology field as well as funds to renovate laboratories in the computer sciences department and to endow a computer science professorship. The company is not particularly interested in patent protection, but wants inventions and computer software to be kept as trade secrets for several years – so it can further develop them in-house and thus obtain a jump on the competition.
Would such an arrangement be contrary to the university’s mission to disseminate knowledge?
Would it undermine the educational experience of students within the department?
![Page 17: Institutional Conflict of Interest and Commercialization Joyce Brinton Director, Office for Technology and Trademark Licensing Harvard University Intellectual](https://reader033.vdocuments.mx/reader033/viewer/2022052401/56649cc15503460f949880b5/html5/thumbnails/17.jpg)
Hypothetical Situation 5
The university is offered $20 million by a large pharmaceutical company in exchange for granting the company a first option to license (on an exclusive basis) any pharmaceutical invention arising from several laboratories over the next five years. The university would not be permitted to enter into sponsored research agreements with other companies that would grant those companies rights to inventions from these laboratories unless the large pharmaceutical company gave its permission.
Would such an arrangement undermine the university’s research mission?
Would such an arrangement be acceptable to the NIH?
![Page 18: Institutional Conflict of Interest and Commercialization Joyce Brinton Director, Office for Technology and Trademark Licensing Harvard University Intellectual](https://reader033.vdocuments.mx/reader033/viewer/2022052401/56649cc15503460f949880b5/html5/thumbnails/18.jpg)
Hypothetical Situation 6
Assistant Professor X and his laboratory have made many inventions over the years and several of them generate considerable income for the university. Professor X is being considered for tenure.
Will the university be influenced in its decision by the fact that Professor X is likely to make more income-producing inventions in the future?
![Page 19: Institutional Conflict of Interest and Commercialization Joyce Brinton Director, Office for Technology and Trademark Licensing Harvard University Intellectual](https://reader033.vdocuments.mx/reader033/viewer/2022052401/56649cc15503460f949880b5/html5/thumbnails/19.jpg)
Hypothetical Situation 7
Several companies are seeking exclusive licenses to an invention. One of the companies is a large donor to the university and/or its president serves on the university’s board of trustees and/or the university has invested heavily on the company’s stock.
If the university selects that company, will the decision be perceived as having been
influenced by this relationship?
![Page 20: Institutional Conflict of Interest and Commercialization Joyce Brinton Director, Office for Technology and Trademark Licensing Harvard University Intellectual](https://reader033.vdocuments.mx/reader033/viewer/2022052401/56649cc15503460f949880b5/html5/thumbnails/20.jpg)
Hypothetical Situation 8
Professor A is working with a venture capitalist to set up a company that will license his invention from the university, with partial payment being made in stock. The company also wants to license Professor B’s invention but Professor B is concerned that a start-up will not be able to develop his technology as well as an established company. The venture capitalist is one with whom the university has worked well on a number of other start-ups and is a large donor to the university.
If the university decides to license Professor B’s technology to the company, will the decision be perceived as driven by the university’s desire to enhance the value of its stock and/or its desire to please a large donor?
![Page 21: Institutional Conflict of Interest and Commercialization Joyce Brinton Director, Office for Technology and Trademark Licensing Harvard University Intellectual](https://reader033.vdocuments.mx/reader033/viewer/2022052401/56649cc15503460f949880b5/html5/thumbnails/21.jpg)
Hypothetical Situations: Common Themes
University has a financial interest:
Stock in a company Prospect of royalties Significant research support from a company
![Page 22: Institutional Conflict of Interest and Commercialization Joyce Brinton Director, Office for Technology and Trademark Licensing Harvard University Intellectual](https://reader033.vdocuments.mx/reader033/viewer/2022052401/56649cc15503460f949880b5/html5/thumbnails/22.jpg)
Having a financial interest in a company
Just because there is a conflict of interest
There is a conflict of interest
The proposed action/activity is unethical or inappropriate
But careful consideration is needed
![Page 23: Institutional Conflict of Interest and Commercialization Joyce Brinton Director, Office for Technology and Trademark Licensing Harvard University Intellectual](https://reader033.vdocuments.mx/reader033/viewer/2022052401/56649cc15503460f949880b5/html5/thumbnails/23.jpg)
Understand that “apparent conflict” can damage
Identify types of institutional conflicts of interest – real and apparent
those that should be prohibited
those that can be managed
Realize that all institutional conflicts cannot be eliminated
Establish review mechanisms
Develop management strategies
Educate decision makers
Don’t get carried away
Summary
![Page 24: Institutional Conflict of Interest and Commercialization Joyce Brinton Director, Office for Technology and Trademark Licensing Harvard University Intellectual](https://reader033.vdocuments.mx/reader033/viewer/2022052401/56649cc15503460f949880b5/html5/thumbnails/24.jpg)
Some Final Thoughts
Technology transfer and economic development activities can create the perception that they conflict with the university’s education, research, and knowledge dissemination missions. Without care, these activities could, in fact, damage the university’s ability to carry out its teaching, research, and knowledge dissemination missions.
![Page 25: Institutional Conflict of Interest and Commercialization Joyce Brinton Director, Office for Technology and Trademark Licensing Harvard University Intellectual](https://reader033.vdocuments.mx/reader033/viewer/2022052401/56649cc15503460f949880b5/html5/thumbnails/25.jpg)
Some Final Thoughts (cont’d)
Technology transfer and economic development pose their own internal conflicts – to what extent does the potential for income generation for the university influence the institution’s decisions regarding the best way for a technology to be developed and brought to market and whether the formation of a start-up company is in the best interests of the technology and the public.